European Agency For The Evaluation Of Medicinal Products Recommends Suspension Of Marketing Authorisation For IONSYS(R)
Nov 21st 2008Drug InformationPain / Anesthetics
Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended suspension of the marketing authorisation for IONSYS(R) (fentanyl iontophoretic transdermal system), indicated for the management of acute moderate to severe post-operative pain for use in a hospital setting only.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
